Announcement PDF 4 December 2023 ASX RELEASE Cornerstone Shareholders Support $700,000 Convertible Note Issuance 4 December 2023, Brisbane: The Calmer Co. International Limited (ASX:CCO), a health and wellness company focussing on natural products that promote calmness, support mind & muscle relaxation and improve sleep advises shareholders that the company has raised $700,000 via convertible notes placed with top shareholders. CEO, Anthony Noble said, “We have secured funding via a short-term convertible note issuance to sophisticated investors all of whom are existing shareholders. This is an overwhelming vote of confidence in the business from our cornerstone stakeholders. Shareholders approved a capital raise of up to $2m at our recent AGM and these notes will all convert to equity following the next share placement on terms detailed in the table below. We believe this plan is in the interests of shareholders. It provides short term funding to the business while allowing the market time to evaluate the strong recent sales growth in both the USA and Australia, along with the new kava-shots that will go onto shelves in Coles from January. These strong sales results should drive value in the business and put us in a good position to raise capital in the new year.” Details of Convertible Note Issuance 140 Convertible Notes have been issued on the following terms: Note Face Value: $5,000 Interest Rate Per Annum: 10%pa fully capitalised at conversion Conversion Date: within 10 days following the next share Placement Conversion at Price Discount: 15% discount to the price of next Placement, or Conversion to Fixed Equity Stake: 0.1% of shares on issue (post conversion) per note Novus Capital was the lead manager on this capital raise and will receive a 6% brokerage fee This release has been approved by the Board of Directors ends for further information Investor & Media Relations Matthew Reede Dominion Communications matt@dominion.partners +61 414 483 054 about The Calmer Co. The Calmer Co. International Limited (ASX:CCO), provides natural solutions to calm nerves, support mind and muscle relaxation and induce sleep. The product range includes drinking powders, teas, shots, concentrates and capsules. Sold under our house of brands: Fiji Kava, Taki Mai and Danodan Hempworks in markets including USA, Australia, China New Zealand and Fiji. The company is also the distributor of Leilo kava drinks in the Fiji Islands. forward looking statements This ASX release includes certain forward-looking statements that are based on information and assumptions known to date and are subject to various risks and uncertainties. Actual results, performance or achievements could be significantly different from those expressed in, or implied by, these forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Fiji Kava. These factors may cause actual results to differ materially from those expressed in the statements contained in this announcement. 2